1. FRI0219 Risk Factors of Severe Infections in Patients with Rheumatoid Arthritis Treated with Tocilizumab in The French Registry Regate (Registry –Roactemra). (15th July 2016) Authors: Morel, J.; Constantin, A.; Dernis, E.; Rist, S.; Flipo, R.M.; Schaeverbeke, T.; Vittecoq, O.; Soubrier, M.; Saraux, A.; Combe, B.; Dougados, M.; Pinta, A.; Baron, G.; Gottenberg, J.-E.; Mariette, X.; Ravaud, P.; Sibilia, J. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 511 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. THU0020 Tocilizumab decreases the pro-inflammatory role of platelets in rheumatoid arthritis: identification of a new mechanism of action associated with positive response?. (12th June 2018) Authors: Prum Delepine, C.; Derambure, C.; Vidal, F.; Pinta, A.; Pau, D.; Conde da Silva Fraga, E.; Boyer, O.; Senbel, E.; Gaudin, P.; Vittecoq, O.; Lequerre, T. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 238 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗